Ascribe Bio Closes $12 Million Series A Financing to Advance Next-Generation Natural Crop Protection Co-Led by Acre Venture Partners and Corteva
Investment drives launch of Phytalix®, a new broad spectrum biofungicide delivering practical, sustainable disease control for farmers globally ITHACA, N.Y. — Ascribe Bio ("Ascribe"), an innovator in natural crop protection, today announced the closing of an
(Financial Post, 2025-10-14T11:20:57Z)